Martínez-Cibrian, N., Ortiz-Maldonado, V., Goñi, C. B., Suñol, P. B., Calvo, M. C., Cassaday, R. D., George, L., Kwon, M., Murthy, G. S. G., Nicholson, E., Richardson, D., Schwartz, M., Wallis, H., Dorman, S., Pulido, S., Reeves, E., Jiang, W., Amet, M., Rajkovic-Potjewyd, I., Reynolds, N., Smith, A. R., Marks, D., Castleton, A. (2025). INO-transit: Inotuzumab ozogamicin treatment prior to chimeric antigen receptor T-cell therapy in Relapsed/Refractory B-cell acute lymphoblastic leukemia: Real-world patient characteristics and outcomes in Spain, the UK and US. Blood. https://doi.org/10.1182/blood-2025-2369